January 2025 - Cingulate completed its final FDA-required study, a food effect study utilizing a single 50-mg dose of ...

Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found tolerable and showed signs of efficacy in a real-world cohort.

The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

High-profile attorney Billy Gibbens confirmed to WDSU that he is now representing Bogalusa Mayor Tyrin Truongin in the case.

The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner. Makary was easily ...

Looking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...

The FDA says the device, designed to repair broken blood vessels to stem bleeding, showed a “clinically meaningful benefit.” ...

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...

With 50 pounds of oxygen tanks, radios and other tools, Quinata and Legaspi’s role was to survey the site of a suspected clandestine drug laboratory ... ensure the proper safety precautions ...